Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1663-2012

Drug recall · September 5, 2012

Bracco Diagnostics multihance recall

Why: Short Fill: The product is being recalled due to a potential underfill of the affected vials.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15

Lots / codes

Lot S1P272A Expiry Date: December 2014

Quantity
47,750 vials
Company
Bracco Diagnostics Inc, Monroe Township, NJ
Distribution
Nationwide
Initiated
April 16, 2012 · Voluntary: Firm initiated
Classified
August 27, 2012
Reported
September 5, 2012
Ended
July 8, 2013
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.